NCT06185569View on ClinicalTrials.gov

FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy

RecruitingOBSERVATIONAL
Enrollment

4,500

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

September 30, 2028

Study Completion Date

March 31, 2029

Conditions
Breast Cancer
Trial Locations (5)

25030

RECRUITING

CHU Besançon, Besançon

33000

RECRUITING

Clinique Tivoli Ducos, Bordeaux

33300

RECRUITING

Polyclinique Bordeaux Nord Aquitaine, Bordeaux

66000

NOT_YET_RECRUITING

Centre Catalan d'Oncologie, Perpignan

75610

RECRUITING

AP-HP - Hôpital Tenon, Paris

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER